12 completed, 6 recruiting, 4 not yet recruiting, 3 unknown. 12 Phase 4, 10 Not applicable, 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 12 | Completed 9, Recruiting 2, Unknown 1 |
| Not applicable | 10 | Recruiting 4, Not yet recruiting 3, Completed 2, Unknown 1 |
| Phase 3 | 2 | Completed 1, Unknown 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Ropivacaine 0.2% Injectable Solution: new trials by email Literature Review of Ropivacaine 0.2% Injectable Solution trials Research Report on Ropivacaine 0.2% Injectable Solution
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ACB and iPACK Blocks With Intravenous Dexamethasone and Perineural Dexmedetomidine in Total Knee Arthroplasty Ropivacaine 0.2% Injectable Solution, Dexamethasone, Dexmedetomidine - Knee Osteoarthritis | Not applicable | Not yet recruiting | Poznan University of Medical Sciences | 120 | 2026-07-01 | 2026-06-30 |
| Lumbar Paravertebral Block vs Erector Spinae Plane Block in Elderly Patients Undergoing Lumbar Spine Surgery Ropivacaine 0.2% Injectable Solution - Spine Disease | Not applicable | Not yet recruiting | Poznan University of Medical Sciences | 120 | 2026-06-01 | 2026-05-26 |
| SII Levels Following PENG Block in Pediatric Hip Surgery Ropivacaine 0.2% Injectable Solution, 0.9%NaCl - Hip Dysplasia | Not applicable | Not yet recruiting | Poznan University of Medical Sciences | 100 | 2026-06-01 | 2026-05-26 |
| SII Levels Following PENG Block in Hip Arthroplasty sodium Chloride, Ropivacaine 0.2% Injectable Solution - Hip Osteoarthritis | Not applicable | Recruiting | Poznan University of Medical Sciences | 60 | 2026-03-01 | 2026-07-01 |
| Three Variants of the PENG Block With and Without Perineural Adjuvants in Older Adults Ropivacaine 0.2% Injectable Solution, Dexamethasone 4mg, Dexmedetomidine - Hip Osteoarthritis | Not applicable | Recruiting | Poznan University of Medical Sciences | 120 | 2026-02-13 | 2026-05-22 |
| PENG Block With Dexmedetomidine in Older Adults Ropivacaine 0.2% Injectable Solution, Dexmedetomidine - Hip Osteoarthritis, Arthropathy of Hip | Not applicable | Recruiting | Poznan University of Medical Sciences | 30 | 2026-02-06 | 2026-03-04 |
| Post Operative Infusion Pump Pain Study Bupivacaine 0.5% Injectable Solution, Ropivacaine 0.2% Injectable Solution, 1.3% liposomal bupivacaine (Exparel) - Post Operative Pain | Phase 4 | Recruiting | Rutgers, The State University of New Jersey | 80 | 2026-01-01 | 2026-01-21 |
| Dexamethasone vs Dexmedetomidine for iPACK + ACB in TKA Ropivacaine 0.2% Injectable Solution, Dexamethasone 4mg, Dexmedetomidine - Knee Osteoarthritis | Not applicable | Recruiting | Poznan University of Medical Sciences | 96 | 2026-01-01 | 2026-02-04 |
| PENG vs L-ESPB With S-ESPB for Analgesia in Total Hip Arthroplasty Ropivacaine 0.5% Injectable Solution, Ropivacaine 0.2% Injectable Solution - Hip Osteoarthritis, Hip Arthropathy | Phase 4 | Recruiting | Poznan University of Medical Sciences | 90 | 2025-09-15 | 2026-05-07 |
| Evaluation of Pain Management After Surgery When Using Nerve Blocks in the Pediatric Population Ropivacaine 0.2% Injectable Solution - Anterior Cruciate Ligament (ACL) Tear, Sports Injuries in Children | Phase 2 | Not yet recruiting | Texas Scottish Rite Hospital for Children | 160 | 2025-09-01 | 2025-09-16 |
| PENG Block Optimization: Volume and Dexamethasone Effects Ropivacaine 0.2% Injectable Solution, Dexamethasone 4mg - Hip Arthropathy, Hip Osteoarthritis | Phase 4 | Completed | Poznan University of Medical Sciences | 120 | 2025-06-25 | 2026-03-16 |
| NLR and PLR Levels Following PENG Block in Hip Arthroplasty 0.9% Sodium Chloride Injection, Ropivacaine 0.2% Injectable Solution - Hip Arthropathy, Hip Osteoarthritis | Phase 4 | Completed | Poznan University of Medical Sciences | 60 | 2025-06-16 | 2025-12-29 |
| Dexamethasone for PENG Block in Total Hip Arthroplasty Ropivacaine 0.2% Injectable Solution, Ropivacaine 0.2% Injectable Solution + 4mg Dexamethasone - Hip Osteoarthritis, Hip Arthropathy | Phase 4 | Completed | Poznan University of Medical Sciences | 60 | 2024-08-13 | 2025-03-24 |
| Ultrasound-guided Infraclavicular Block With Lidocaine or Ropivacaine for Closed Reduction of Distal Radius Fractures Ropivacaine 0.2% Injectable Solution, Lidocaine epinephrine, Ropivacaine 0.5% Injectable Solution - Distal Radius Fractures, Lidocaine | Phase 3 | Completed | Nordsjaellands Hospital | 67 | 2024-04-23 | 2025-06-26 |
| ESPB vs iPACK+ACB in Total Knee Arthroplasty Ropivacaine 0.2% Injectable Solution, control group - Knee Arthritis, Knee Arthropathy | Phase 4 | Unknown | Poznan University of Medical Sciences | 60 | 2024-04-01 | 2024-03-08 |
| NLR and PLR Levels Following IPACK Block in Knee Arthroplasty 0.9% Sodium Chloride Injection, Ropivacaine 0.2% Injectable Solution - Knee Arthropathy, Knee Osteoarthritis | Phase 4 | Completed | Poznan University of Medical Sciences | 60 | 2024-03-30 | 2025-03-24 |
| Regional Anesthesia Following Pediatric Cardiac Surgery Regional Anesthesia, Wound infiltration, Ropivacaine 0.2% Injectable Solution - Atrial Septal Defect, Ventricular Septal Defect | Phase 4 | Completed | Duke University | 52 | 2023-03-29 | 2025-08-28 |
| Erector Spine Plane (ESP) Block for Analgesia in Pediatric Scoliosis Surgery Ropivacaine 0.2% Injectable Solution, Normal saline 0.9% Injectable Solution - Scoliosis, Regional Anesthesia | Not applicable | Unknown | Poznan University of Medical Sciences | 50 | 2022-09-08 | 2023-07-13 |
| Comparison Erect Spine in Cardiac Surgery Ropivacaine 0.2% Injectable Solution, Ropivacaine 0.2% + Dexamethasone - Spine Erector, Cardiac Surgery | Phase 3 | Unknown | Instituto do Coracao | 40 | 2022-01-20 | 2022-07-18 |
| Paravertebral Block to Reduce the Incidence of New Onset Atrial Fibrillation After Cardiac Surgery Ropivacaine 0.2% Injectable Solution - New Onset Atrial Fibrillation, Anesthesia, Local | Phase 4 | Completed | University of Minnesota | 32 | 2021-04-09 | 2025-08-05 |
Showing 20 of 25. Sign in to see all of them.
Osteoarthritis, Hip (7) · Osteoarthritis, Knee (6) · Pain, Postoperative (4) · Agnosia (3) · Acute Pain (2) · Chronic Pain (1) · Colles' Fracture (1) · Fracture Dislocation (1) · Gender Dysphoria (1) · Heart Diseases (1) · Heart Septal Defects, Atrial (1) · Heart Septal Defects, Ventricular (1) · Hip Dislocation (1) · Lacerations (1) · Lung Neoplasms (1)
Poznan University of Medical Sciences (15) · Centre Hospitalier Universitaire Vaudois (1) · Duke University (1) · Instituto do Coracao (1) · Nordsjaellands Hospital (1) · Paola M Zamora Munoz (1) · Rutgers, The State University of New Jersey (1) · Surgery Bitenc (1) · Texas Scottish Rite Hospital for Children (1) · University of California, San Francisco (1) · University of Minnesota (1)
Poland (15) · United States (5) · Brazil (1) · Denmark (1) · Mexico (1) · Slovenia (1) · Switzerland (1)
Malgorzata Reysner, MD PhD (4) · Malgorzata Reysner, M.D. Ph.D. (2) · Esther Kim, MD (1) · James Flaherty, MD (1) · Katarzyna Wieczorowska-Tobis, MD PhD (1) · Lisa M Einhorn, MD (1) · Luis Alberto Rodriguez Linares, MD (1) · Malgorzata Domagalska, M.D. Ph.D. (1) · Malgorzata Domagalska, Ph.D. (1) · Malgorzata Reysner (1)
PMID 37220393, PMID 41032451, PMID 42104772, PMID 42148589, PMID 42243419, PMID 42723015